Initially wasn’t going to post this, as I thought: “Oh well, probably nothing to do with MS”.
But then I read there are unconfirmed reports the drug being tested was a “cannabis-based painkiller”. I know many of us, including me, are interested in this development area.
Apparently six volunteers “in a critical condition” - one in a coma - after testing the drug.
Full story at the BBC, here: www.bbc.co.uk/news/world-europe-35320895
I hope I’m not scaremongering, but I thought it’s relevant to us. I also thought it’s an illustration that clinical trials, however exciting, are never risk free.
Of course, we don’t know yet what went wrong. Was it a reaction to the drug itself, or did somebody make a huge mistake with the dosing?